Heron Therapeutics(HRTX) Prnewswire·2025-02-13 21:20Core Viewpoint - Heron Therapeutics, Inc. will host a conference call and live webcast on February 27, 2025, to report its fourth quarter and full year 2024 financial results and discuss recent business highlights [1]. Company Overview - Heron Therapeutics, Inc. is a commercial-stage biotechnology company focused on developing and commercializing therapeutic innovations aimed at improving medical care for patients [3]. - The company utilizes advanced science, patented technologies, and an innovative approach to drug discovery and development to create a portfolio of products that enhance the standard-of-care for acute care and oncology patients [3]. Conference Call Details - The conference call can be accessed via a registration link that provides dial-in details, and participants are encouraged to join fifteen minutes early to avoid delays [2]. - The call will also be available through a webcast on Heron's website, with an archive accessible for 60 days following the event [2].